EQL Pharma’s melatonin tablets approved in Denmark and Norway
EQL Pharma has today received market approval for its melatonin tablets 0.5mg, 1mg, 2mg, 3mg, 4mg, 5mg in Denmark and Norway. The brand will, just like in Sweden, be "Mellozzan" in Denmark, but will be sold in Norway under the brand "Mallozen".EQL's melatonin is a prescription drug used to treat insomnia in children 6 - 17 years with ADHD where other sleep support measures are not sufficient. It can also be taken by adults to treat the effects of jet lag for a short time. The Norwegian market currently has two registered competitors, one of which with only the jet lag indication, and